Applied Imaging subject to Nasdaq-delisting
This article was originally published in Clinica
Applied Imaging could face being delisted from Nasdaq after failing to file its quarterly report for the period ended September 30 2004 with the US Securities and Exchange Commission. The company's appeal against the delisting is under review by the Nasdaq Listing Qualifications Panel. Until the final determination, the date of which is not known, the company's shares will be traded under an amended trading symbol.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.